CSL (ASX: CSL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
CSL Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
CSL (ASX: CSL)
Latest News
Blue Chip Shares
3 unstoppable ASX 200 stocks to buy and hold forever
Broker Notes
Bell Potter names more of the best ASX 200 stocks to buy in April
Share Fallers
11 popular ASX 200 shares crashing to multi-year lows amid market carnage
How to invest
Here's a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!
Broker Notes
10 ASX shares to buy after the market selloff
Healthcare Shares
Broker laments 'catastrophic negative surprise' that highlights the risks with these types of ASX shares
Share Market News
ASX 200 plunges as US tariffs fall-out continues
Defensive Shares
Is CSL the most defensive ASX stock on the market?
Growth Shares
5 of the best ASX shares to buy after the market selloff
Blue Chip Shares
3 no-brainer ASX 200 shares to buy after the market selloff
How to invest
The power of compounding: What your ASX share portfolio could become by 2040
Retirement
Want to retire rich? I would invest $1,000 a month into ASX shares
Frequently Asked Questions
-
CSL was listed on the ASX in June 1994.
-
CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.
Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.
-
CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.
-
CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents.
CSL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About CSL
CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.
CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.
CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).
The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.
